These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Henke H, Lang W. Brain Res; 1983 May 16; 267(2):281-91. PubMed ID: 6871677 [Abstract] [Full Text] [Related]
3. Pre- and postsynaptic neurochemical alterations in Alzheimer's disease. Reisine TD, Yamamura HI, Bird ED, Spokes E, Enna SJ. Brain Res; 1978 Dec 29; 159(2):477-81. PubMed ID: 215272 [No Abstract] [Full Text] [Related]
4. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes. Rossor MN, Svendsen C, Hunt SP, Mountjoy CQ, Roth M, Iversen LL. Neurosci Lett; 1982 Feb 12; 28(2):217-22. PubMed ID: 7070710 [Abstract] [Full Text] [Related]
5. A post-mortem study of the cholinergic and GABA systems in senile dementia. Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL. Brain; 1982 Jun 12; 105(Pt 2):313-30. PubMed ID: 7082992 [Abstract] [Full Text] [Related]
6. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide. Rossor M, Fahrenkrug J, Emson P, Mountjoy C, Iversen L, Roth M. Brain Res; 1980 Nov 10; 201(1):249-53. PubMed ID: 7417838 [Abstract] [Full Text] [Related]